Drug development is the process in which a new pharmaceutical drug comes into the market once a lead compound has been identified through the various process and stages of drug discovery. Drug design mostly referred to as rational drug design or simply rational design, where the inventive process of searching new medications are based on the knowledge of a biological target. The drug is a small organic molecule which plays a role to activate or inhibit the function of a biomolecule such as a protein, that in turn results in a therapeutic benefit to the patient. Basically, drug design involves the design of molecules those are complementary in shape & charge to the biomolecular target with which they can interact and as a result will bind to it. A generic drug is a pharmaceutical drug which is equivalent to a brand-name product in dosage, quality, performance, strength, route of administration, and intended use. In the stages of drug development research, the preclinical development which is also named as preclinical studies and nonclinical studies, that initiates before clinical trials can begin, and during which important feasibility, iterative testing & drug safety data are collected. To discover and explore into the recent researches and on-going projects in the different region, join your peers at Clinical Pharmacy Congress at Bangkok, Thailand.
- Advanced Technologies Involved in Drug Discovery
- FDA Post-Market Safety Monitoring